Please upgrade to the latest version of Flash Player.
Click here if you already have Flash Player installed.

The diagnosis of uveitis in the eye will often be made by your eye care provider. It will be based on your ocular symptoms and findings on detailed microscopic examination of the eye. The location of the inflammation may be determined by examination. This will allow the eye doctor to determine the type of uveitis. Further testing using Ultrasound imaging (B-scan), Optical Coherence Tomography (OCT), and Fluorescein Angiography (RSFA or FA) may be required to determine the nature of the inflammation and its effects (anatomic and functional) on the eye.
Laboratory testing will be required for most forms of uveitis. This typically includes skin tests for Tuberculosis, blood tests for infectious diseases like syphilis, Lyme disease, Cat scratch disease, Histoplasmosis, and blood tests for other auto-immune diseases such as Lupus, Sarcoidosis, rheumatoid arthritis and many others.
Surgery may be required to determine the cause of the inflammation allowing us to safely biopsy the vitreous or fluid in the front of the eye. This fluid and the cells within it can be examined microscopically by a pathologist and/or cultured for infectious agents, and/or be evaluated using PCR (a form of DNA fingerprinting called Polymerase chain reaction).
Despite all of the available testing methods, about 50% to 66% (1/2 to 2/3) of patient with uveitis will not have any known identifiable cause.
Treatment of uveitis is based on the cause of the uveitis.
Infectious causes (such as syphilis, tuberculosis, Lyme disease, cat scratch disease) are treated with antibiotics often combined with corticosteroids (potent anti-inflammatory agents).
Non-infectious causes (autoimmune conditions) are generally treated with corticosteroids. These may be given as drops, depot injections in or around the eye, and/or pills. Steroids are extremely effective in reducing inflammation quickly. Ocular complications from steroids include cataract and glaucoma. But if the inflammation in the eye is not well controlled, cataract and glaucoma may result. So, steroid therapy can control but not cure the uveitis. Treatment involves creating a balance between treatment and disease and reducing side effects of treatment and disease.
If non infectious causes do not respond to treatment with steroids or cannot be tolerated due to severe side effects, other agents (cytotoxic or cystostatic immunosuppressives) are often utilized. These agents include methotrexate, azathioprine (Imuran), cyclosporine A (Neoral, Sandimmune), and cyclophosphamide (cytoxan). Other newer agents called biologics may also be used if immunosuppressives fail. These biologics include Infliximab (Remicade) and Etarnercept (Enbrel). These agents are typically managed in conjunction with a rheumatologist, an internal medicine doctor who specializes in the treatment of autoimmune disorders. The choice of which agents to use will be decided upon by the patient, uveitis specialist, and the rheumatologist.